Ezra Klein challenges the notion that patients in the United States get better cancer treatment than patients in other developed countries.
Klein goes on to report that actual death rates (in the U.S. population) have not really changed for many cancers, despite much greater detection. Further, this epidemic of over diagnosis can cause harm, because people will undergo surgery who don’t need it.
Although this argument is not trivial, I find it hard to accept.
Read the entire column at the National Center for Policy Analysis Health Policy Blog or the Independent Institute's Beacon Blog.